A share that finally<br>needs to go public. #29385a

Become one of the exclusive 30 investors taking DAVIGOworx public! Secure your place in the consortium now.

The investment company DAVIGOworx GmbH & Co KGaA is on the verge of a significant step: It is offering a "stock exchange-ready" share for issuance, whose investment strategy is fully developed and tested. To realize the successful IPO in the premium over-the-counter market plus XETRA, DAVIGOworx is forming a consortium of 30 investors who will provide capital for drawdown as part of a private placement.

Contact us directly if you are interested.

Completed investments
from the practical test portfolio*

DECIPHERA PHARMACEUTICALS IN

DECIPHERA PHARMACEUTICALS IN

Sell (year) :2024
Holding period (years) :1.1
+61.8%
NEOGAMES SA

NEOGAMES SA

Sell (year) :2024
Holding period (years) :0.9
+8.3%
HIBBETT INC

HIBBETT INC

Sell (year) :2024
Holding period (years) :1.2
+21.8%
ALPINE IMMUNE SCIENCES INC

ALPINE IMMUNE SCIENCES INC

Sell (year) :2024
Holding period (years) :1.0
+779.0%
SHOCKWAVE MEDICAL INC

SHOCKWAVE MEDICAL INC

Sell (year) :2024
Holding period (years) :1.1
+66.7%
SOVOS BRANDS INC

SOVOS BRANDS INC

Sell (year) :2024
Holding period (years) :0.9
+31.1%
TEXTAINER GROUP HOLDINGS LTD

TEXTAINER GROUP HOLDINGS LTD

Sell (year) :2024
Holding period (years) :1.0
+51.8%
DISCOVER FINANCIAL SERVICES

DISCOVER FINANCIAL SERVICES

Sell (year) :2024
Holding period (years) :0.8
+21.0%
MASONITE INTERNATIONAL CORP

MASONITE INTERNATIONAL CORP

Sell (year) :2024
Holding period (years) :1.0
+49.4%
CYMABAY THERAPEUTICS INC

CYMABAY THERAPEUTICS INC

Sell (year) :2024
Holding period (years) :0.9
+261.1%
MCGRATH RENTCORP

MCGRATH RENTCORP

Sell (year) :2024
Holding period (years) :1.0
+15.4%
QIAGEN N.V.

QIAGEN N.V.

Sell (year) :2024
Holding period (years) :0.9
-5.1%
OVERSEAS SHIPHOLDING GROUP-A

OVERSEAS SHIPHOLDING GROUP-A

Sell (year) :2024
Holding period (years) :0.9
+70.4%
ENGAGESMART INC

ENGAGESMART INC

Sell (year) :2024
Holding period (years) :0.8
+33.6%
INHIBRX INC

INHIBRX INC

Sell (year) :2024
Holding period (years) :0.7
+73.3%
KAMAN CORP

KAMAN CORP

Sell (year) :2024
Holding period (years) :0.9
+80.3%
MDC HOLDINGS INC

MDC HOLDINGS INC

Sell (year) :2024
Holding period (years) :0.9
+67.0%
CARROLS RESTAURANT GROUP INC

CARROLS RESTAURANT GROUP INC

Sell (year) :2024
Holding period (years) :0.8
+358.5%
FIRST FINANCIAL NORTHWEST

FIRST FINANCIAL NORTHWEST

Sell (year) :2024
Holding period (years) :0.9
+34.7%
ANSYS INC

ANSYS INC

Sell (year) :2024
Holding period (years) :0.9
+21.3%
JUNIPER NETWORKS INC

JUNIPER NETWORKS INC

Sell (year) :2024
Holding period (years) :0.8
+16.4%
AXONICS INC

AXONICS INC

Sell (year) :2024
Holding period (years) :0.8
+20.4%
ENETI INC

ENETI INC

Sell (year) :2024
Holding period (years) :0.7
+10.4%
DASEKE INC

DASEKE INC

Sell (year) :2023
Holding period (years) :0.8
-4.6%
KARUNA THERAPEUTICS INC

KARUNA THERAPEUTICS INC

Sell (year) :2023
Holding period (years) :0.7
+71.9%
CEREVEL THERAPEUTICS HOLDING

CEREVEL THERAPEUTICS HOLDING

Sell (year) :2023
Holding period (years) :0.7
+66.0%
ALTERYX INC - CLASS A

ALTERYX INC - CLASS A

Sell (year) :2023
Holding period (years) :0.8
-29.5%
PGT INNOVATIONS INC

PGT INNOVATIONS INC

Sell (year) :2023
Holding period (years) :0.8
+82.3%
UNITED STATES STEEL CORP

UNITED STATES STEEL CORP

Sell (year) :2023
Holding period (years) :0.8
+68.1%
ICOSAVAX INC

ICOSAVAX INC

Sell (year) :2023
Holding period (years) :0.6
+114.5%
IMMUNOGEN INC

IMMUNOGEN INC

Sell (year) :2023
Holding period (years) :0.8
+618.8%
VERITIV CORP

VERITIV CORP

Sell (year) :2023
Holding period (years) :0.8
+22.3%
ROVER GROUP INC

ROVER GROUP INC

Sell (year) :2023
Holding period (years) :0.6
+149.9%
VMWARE INC-CLASS A

VMWARE INC-CLASS A

Sell (year) :2023
Holding period (years) :0.7
+20.5%
ARGO GROUP INTERNATIONAL

ARGO GROUP INTERNATIONAL

Sell (year) :2023
Holding period (years) :0.7
+2.2%
NEW RELIC INC

NEW RELIC INC

Sell (year) :2023
Holding period (years) :0.7
+15.9%
BLUEGREEN VACATIONS HOLDING

BLUEGREEN VACATIONS HOLDING

Sell (year) :2023
Holding period (years) :0.6
+154.3%
TABULA RASA HEALTHCARE INC

TABULA RASA HEALTHCARE INC

Sell (year) :2023
Holding period (years) :0.7
+72.4%
SPIRIT REALTY CAPITAL INC

SPIRIT REALTY CAPITAL INC

Sell (year) :2023
Holding period (years) :0.4
-10.5%
FIESTA RESTAURANT GROUP

FIESTA RESTAURANT GROUP

Sell (year) :2023
Holding period (years) :0.7
+1.9%
CIRCOR INTERNATIONAL INC

CIRCOR INTERNATIONAL INC

Sell (year) :2023
Holding period (years) :0.7
+108.3%
HERITAGE-CRYSTAL CLEAN INC

HERITAGE-CRYSTAL CLEAN INC

Sell (year) :2023
Holding period (years) :0.7
+19.5%
ACTIVISION BLIZZARD INC

ACTIVISION BLIZZARD INC

Sell (year) :2023
Holding period (years) :0.6
+19.4%
NATIONAL INSTRUMENTS CORP

NATIONAL INSTRUMENTS CORP

Sell (year) :2023
Holding period (years) :0.5
+15.9%
PIONEER NATURAL RESOURCES CO

PIONEER NATURAL RESOURCES CO

Sell (year) :2023
Holding period (years) :0.5
+6.9%
MIRATI THERAPEUTICS INC

MIRATI THERAPEUTICS INC

Sell (year) :2023
Holding period (years) :0.4
+14.5%
NATIONAL WESTERN LIFE GROU-A

NATIONAL WESTERN LIFE GROU-A

Sell (year) :2023
Holding period (years) :0.6
+84.6%
SP PLUS CORP

SP PLUS CORP

Sell (year) :2023
Holding period (years) :0.6
+32.3%
HORIZON THERAPEUTICS PLC

HORIZON THERAPEUTICS PLC

Sell (year) :2023
Holding period (years) :0.5
+4.3%
LIVEVOX HOLDINGS INC

LIVEVOX HOLDINGS INC

Sell (year) :2023
Holding period (years) :0.5
+24.9%

*Past returns are not an indicator of future returns.

For the acquisition of publicly listed company shares, DAVIGOworx utilizes its self-developed software "Yield Finder." This investment technology has been extensively used in a practical test portfolio since August 2018. Since then, a total of 2,222 company shares (as of April 30, 2024) have been acquired and subsequently sold – with very positive results. The average profit per sold company share in the practical test portfolio was 62.6 percent as of April 30, 2024, with an average holding period per company share of 2.1 years. This corresponds to an average of 25.4 percent p.a. per investment. These were almost exclusively U.S. companies included in broad U.S. indices.

DAVIGOworx revolutionizes the investment market with a unique publicly traded share that innovatively combines Public and Private Equity.

We will bundle thousands of company investments in a single, liquid security, making diversified investing accessible to all.

Our data-driven approach combines the strengths of Public and Private Equity: while we primarily focus on small and mid-caps in the Public Equity sector, a balanced portfolio across vintages, stages, regions, and sectors will emerge in the Private Equity segment - in collaboration with VC/PE experts.

This agile combination of both asset classes will enable stabilization and maximization of capital efficiency with daily tradability - a decisive advantage over traditionally illiquid PE investments.

The transparency and easy integration into existing investment guidelines make us particularly attractive to institutional investors, while private investors benefit from the ability to comprehensively diversify their portfolio with a single share.

Our goal is to establish the DAVIGOworx share as an indispensable component in every investor's portfolio. Become part of the DAVIGOworx investor consortium and shape the future of diversified investing with us - with a scalable, future-oriented investment solution that redefines the boundaries between Public and Private Equity.

DAVIGOworx offers long-term
wealth management with daily
availability – in a single stock

  • Long-term focused investment strategy
  • Data-driven approach
  • Immediate and continuous diversification of investment capital
  • Balanced portfolio across asset classes, strategies, vintages, phases, regions, and sectors
  • Agile bundling of investments in thousands of public and private companies – worldwide and simultaneously
  • No entry barriers
  • No capital lock-up periods

Questions and Answers

DAVIGOworx is the revolutionary stock that will unite Public and Private Equity in a single, liquid security. Thousands of company investments, a data-driven approach, and daily tradability will make DAVIGOworx the future of diversified investing. Whether you're a private investor or an institutional investor - with DAVIGOworx, you'll experience how we redefine the boundaries of traditional asset classes and take every (!) portfolio to the next level.

Our primary goal is initially to enter the premium over-the-counter market plus XETRA. However, this is just the beginning: We are striving to switch to the regulated market as quickly as possible to further strengthen our market position and become attractive to an even broader spectrum of investors.

The path to the stock exchange follows clearly defined steps. First, we form a consortium of 30 investors who provide capital for drawdown as part of a private placement. Once the stock exchange admission criteria for the premium over-the-counter market are met, we will call on the capital commitments, with which the investors will subscribe to the DWRX24 shares. The listing will take place a few days later. The collected capital will flow exclusively into portfolio building and growth-promoting measures.

After the IPO, we will focus on a strategy of continuous growth. We plan regular capital increases, supported by massive marketing towards retail investors and targeted engagement with institutional partners such as issuing banks and selling agents. Our goal is to steadily increase the liquidity of DAVIGOworx stock and make it attractive to an increasingly broader range of investor groups.

Yes, the initial members of the consortium have the exclusive opportunity to participate directly in DAVIGOworx Management GmbH, provided certain requirements are met. This is the fintech behind DAVIGOworx and potentially offers significant growth opportunities.

We have established a clear process to protect the interests of all parties involved. The capital will only be called once all 30 consortium partners are secured and the stock exchange listing requirements are met. This ensures that we can enter the market with the necessary strength and capital.

Contact-Form

Fields marked with * are mandatory.

Note

The information on this website represents promotional preliminary information for a planned public offering of shares by DAVIGOworx GmbH & Co. KGaA in the form of a private placement using the prospectus exemption under Art. 1 Para. 4 lit c) Regulation (EU) 2017/1129. The standard minimum subscription amount shall be EUR 1 million, in no case less than EUR 100,000. The information on this website is not sufficient to make a purchase decision and does not replace complete and final information from DAVIGOworx GmbH & Co. KGaA. Therefore, the information on this website does not constitute an offer to purchase shares.

Warning: The acquisition of shares involves substantial risks and may lead to the complete loss of invested capital.